Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan;38(1):411-453.
doi: 10.1002/ptr.8033. Epub 2023 Dec 5.

Traditional Chinese medicines treat ischemic stroke and their main bioactive constituents and mechanisms

Genhao Fan  1   2 , Menglin Liu  1 , Jia Liu  2 , Yuhong Huang  2 , Wei Mu  2
Affiliations
Review

Traditional Chinese medicines treat ischemic stroke and their main bioactive constituents and mechanisms

Genhao Fan et al. Phytother Res. 2024 Jan.

Abstract

Ischemic stroke (IS) remains one of the leading causes of death and disability in humans. Unfortunately, none of the treatments effectively provide functional benefits to patients with IS, although many do so by targeting different aspects of the ischemic cascade response. The advantages of traditional Chinese medicine (TCM) in preventing and treating IS are obvious in terms of early treatment and global coordination. The efficacy of TCM and its bioactive constituents has been scientifically proven over the past decades. Based on clinical trials, this article provides a review of commonly used TCM patent medicines and herbal decoctions indicated for IS. In addition, this paper also reviews the mechanisms of bioactive constituents in TCM for the treatment of IS in recent years, both domestically and internationally. A comprehensive review of preclinical and clinical studies will hopefully provide new ideas to address the threat of IS.

Keywords: bioactive constituents; ischemic stroke; mechanism; pharmacology; target; traditional Chinese medicine.

PubMed Disclaimer

References

REFERENCES

    1. Abe, K. (2000). Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. Journal of Cerebral Blood Flow and Metabolism, 20(10), 1393-1408.
    1. Aixiang, F. (2019). Effect of combined Chinese and Western medicine therapy on neurological recovery in patients with acute ischemic stroke. Journal of Henan University of Chinese Medicine, 39(3), 384-387.
    1. Al Dera, H. (2017). Neuroprotective effect of resveratrol against late cerebral ischemia reperfusion induced oxidative stress damage involves upregulation of osteopontin and inhibition of interleukin-1beta. Journal of Physiology and Pharmacology, 68(1), 47-56.
    1. An, H., Tao, W., Liang, Y., Li, P., Li, M., Zhang, X., Chen, K., Wei, D., Xie, D., & Zhang, Z. (2021). Dengzhanxixin injection ameliorates cognitive impairment through a neuroprotective mechanism based on mitochondrial preservation in patients with acute ischemic stroke. Frontiers in Pharmacology, 12, 712436.
    1. Anrather, J., & Iadecola, C. (2016). Inflammation and stroke: An overview. Neurotherapeutics, 13(4), 661-670.

MeSH terms

Substances

LinkOut - more resources